Cargando…

DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population

INTRODUCTION: DNA methylation of CpG islands within the promoter region of genes is an epigenetic modification with an important role in the development of cancer and it is typically mediated by DNA methyltransferases (DNMTs). In cancer cells, global hypomethylation of the genome as a whole and regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kullmann, Kathrin, Deryal, Mustafa, Ong, Mei Fang, Schmidt, Werner, Mahlknecht, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646668/
https://www.ncbi.nlm.nih.gov/pubmed/23638630
http://dx.doi.org/10.1186/1868-7083-5-7
_version_ 1782268619055431680
author Kullmann, Kathrin
Deryal, Mustafa
Ong, Mei Fang
Schmidt, Werner
Mahlknecht, Ulrich
author_facet Kullmann, Kathrin
Deryal, Mustafa
Ong, Mei Fang
Schmidt, Werner
Mahlknecht, Ulrich
author_sort Kullmann, Kathrin
collection PubMed
description INTRODUCTION: DNA methylation of CpG islands within the promoter region of genes is an epigenetic modification with an important role in the development of cancer and it is typically mediated by DNA methyltransferases (DNMTs). In cancer cells, global hypomethylation of the genome as a whole and regional hypermethylation of CpG islands have been reported. Four groups of DNMTs have been identified: DNMT1, DNMT2 (TRDMT1), DNMT3A and DNMT3B. DNMT2 uses the catalytic mechanism of DNMTs, but does in fact methylate RNA. Little is known about the significance of these genes in human breast cancer. In the study presented herein, we analyzed five distinct DNMT single SNPs with regard to potential associations with breast cancer risk. CASE DESCRIPTION: In this study, we genotyped 221 female Caucasian breast cancer patients and 221 female Caucasian healthy controls, and we used five allele-specific real-time polymerase chain reaction (qPCR) assays. We selected one locus within the DNMT1 gene and two loci within the DNMT3A and DNMT3B genes, respectively. Statistics were calculated using the chi-squared and Fisher’s exact tests, and correlated with clinical parameters such as age, diagnosis, histology, TNM stage, hormonal receptor status, human epidermal growth factor receptor 2 (HER2) status, response to treatment and survival. Statistically significant results were obtained for correlations with the DNMT1 gene. DISCUSSION AND EVALUATION: Five genomic loci within the DNMT1, DNMT3A and DNMT3B genes were assessed. Statistical significance (P = 0.030) was identified for DNMT1 SNP (A201G, rs2228612): six women within the control group were GG homozygous (variant), while this mutation was absent in the breast cancer group. CONCLUSIONS: We conclude that women with the DNMT1 SNP (A201G, rs2228612) GG homozygous genotype (variant) have a lower risk of developing breast cancer compared to heterozygous or wildtype genotypes. To date, alterations within the DNMT1 gene have not been reported to be associated with cancer in the Caucasian population.
format Online
Article
Text
id pubmed-3646668
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36466682013-05-08 DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population Kullmann, Kathrin Deryal, Mustafa Ong, Mei Fang Schmidt, Werner Mahlknecht, Ulrich Clin Epigenetics Case Study INTRODUCTION: DNA methylation of CpG islands within the promoter region of genes is an epigenetic modification with an important role in the development of cancer and it is typically mediated by DNA methyltransferases (DNMTs). In cancer cells, global hypomethylation of the genome as a whole and regional hypermethylation of CpG islands have been reported. Four groups of DNMTs have been identified: DNMT1, DNMT2 (TRDMT1), DNMT3A and DNMT3B. DNMT2 uses the catalytic mechanism of DNMTs, but does in fact methylate RNA. Little is known about the significance of these genes in human breast cancer. In the study presented herein, we analyzed five distinct DNMT single SNPs with regard to potential associations with breast cancer risk. CASE DESCRIPTION: In this study, we genotyped 221 female Caucasian breast cancer patients and 221 female Caucasian healthy controls, and we used five allele-specific real-time polymerase chain reaction (qPCR) assays. We selected one locus within the DNMT1 gene and two loci within the DNMT3A and DNMT3B genes, respectively. Statistics were calculated using the chi-squared and Fisher’s exact tests, and correlated with clinical parameters such as age, diagnosis, histology, TNM stage, hormonal receptor status, human epidermal growth factor receptor 2 (HER2) status, response to treatment and survival. Statistically significant results were obtained for correlations with the DNMT1 gene. DISCUSSION AND EVALUATION: Five genomic loci within the DNMT1, DNMT3A and DNMT3B genes were assessed. Statistical significance (P = 0.030) was identified for DNMT1 SNP (A201G, rs2228612): six women within the control group were GG homozygous (variant), while this mutation was absent in the breast cancer group. CONCLUSIONS: We conclude that women with the DNMT1 SNP (A201G, rs2228612) GG homozygous genotype (variant) have a lower risk of developing breast cancer compared to heterozygous or wildtype genotypes. To date, alterations within the DNMT1 gene have not been reported to be associated with cancer in the Caucasian population. BioMed Central 2013-05-02 /pmc/articles/PMC3646668/ /pubmed/23638630 http://dx.doi.org/10.1186/1868-7083-5-7 Text en Copyright © 2013 Kullmann et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Study
Kullmann, Kathrin
Deryal, Mustafa
Ong, Mei Fang
Schmidt, Werner
Mahlknecht, Ulrich
DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
title DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
title_full DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
title_fullStr DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
title_full_unstemmed DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
title_short DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
title_sort dnmt1 genetic polymorphisms affect breast cancer risk in the central european caucasian population
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646668/
https://www.ncbi.nlm.nih.gov/pubmed/23638630
http://dx.doi.org/10.1186/1868-7083-5-7
work_keys_str_mv AT kullmannkathrin dnmt1geneticpolymorphismsaffectbreastcancerriskinthecentraleuropeancaucasianpopulation
AT deryalmustafa dnmt1geneticpolymorphismsaffectbreastcancerriskinthecentraleuropeancaucasianpopulation
AT ongmeifang dnmt1geneticpolymorphismsaffectbreastcancerriskinthecentraleuropeancaucasianpopulation
AT schmidtwerner dnmt1geneticpolymorphismsaffectbreastcancerriskinthecentraleuropeancaucasianpopulation
AT mahlknechtulrich dnmt1geneticpolymorphismsaffectbreastcancerriskinthecentraleuropeancaucasianpopulation